Grainne Quinn
Chief Tech/Sci/R&D Officer bij PERRIGO COMPANY PLC
Vermogen: 678 501 $ op 31-03-2024
Profiel
Momenteel bekleedt Grainne Quinn de functie van Chief Medical Officer & Executive Vice President bij Perrigo Co. Plc. Dr. Quinn bekleedde voorheen de functie van Chief Medical Officer bij Elan Corp. Plc. Dr. Quinn behaalde een doctoraat aan het Royal College of Surgeons.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
PERRIGO CO. PLC
0.02% | 05-04-2024 | 21 078 ( 0.02% ) | 678 501 $ | 31-03-2024 |
Actieve functies van Grainne Quinn
| Bedrijven | Functie | Begin |
|---|---|---|
| PERRIGO COMPANY PLC | Chief Tech/Sci/R&D Officer | 01-11-2015 |
Eerdere bekende functies van Grainne Quinn
| Bedrijven | Functie | Einde |
|---|---|---|
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Chief Tech/Sci/R&D Officer | 01-12-2013 |
Opleiding van Grainne Quinn
| Royal College of Surgeons | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PERRIGO COMPANY PLC | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Health Technology |
